A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

GEORGE F. LEE / GLEE @STARADVERTISER.COM The University of Hawaii Cancer Center in Kakaako as seen Thursday. GEORGE F. LEE / ...

Oncologist Dr. Sarah Cate told Newsweek: "Many women simply don't make time for themselves, since they are working and often ...

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

Aging research has experienced substantial advancements in the past decade, particularly in understanding the interrelation ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

West Cancer Center & Research Institute, a leader in oncology care, has teamed up with EngagedMD, a leader in digital patient ...

Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

As part of The Wistar Institute’s Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT.